Ketamine associated vomiting in children require sedation

Study of the association of various ketamine doses with vomiting in children requiring sedation in the emergency department

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151114025027N6

Enrollment

200

Registered

2018-04-12

Start date

2018-04-21

Completion date

Unknown

Last updated

2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vomiting. Vomiting

Interventions

Intervention 1: Patients in first group will receive ketamine via intravenous with dosage of 1 mg/kg. Intervention 2: Intervention group: Patients in Second group will receive ketamine via intravenous

Eligibility

Sex/Gender

All

Age

4 Months to 13 Years

Inclusion criteria

Inclusion criteria: Patients who require sedation for therapeutic or diagnostic process (reduction of fractures, CT scan, stitches, etc.) aged between 4 months to 13 years

Exclusion criteria

Exclusion criteria: patients less than 3 months and more than 13 years patients who had vomiting before sedation patients who did not receive single-dose medication patients who suspected increased ICP asthma or previous adverse reaction to ketamine cardiovascular diseases or hypertension airway tract infections porphyria

Design outcomes

Primary

Measure	Time frame
Vomiting. Timepoint: 2 hours after injection. Method of measurement: Visual analog scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadreza Maleki Varaki

Ahvaz University of Medical Sciences

Maleki-m@ajums.ac+98 61 3320 8342

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026